In the attached report which was just published online in the journal BLOOD, we show how these mutations impact disease presentation and overall survival in WM. CXCR4 is a gene that makes a protein that directs cells to the bone marrow. It also impacts how ibrutinib works.
Dana Farber Cancer Institute, Harvard Medical School
Bing Center for Waldenstrom’s Macroglobulinemia